Enveric Biosciences, Inc. (ENVB)Healthcare | Biotechnology | Cambridge, United States | NasdaqCM
1.37 USD
-0.03
(-2.143%) ⇩
(Oct. 14, 2026, 4 p.m.
EDT)
After hours: 1.34 -0.03 (-0.030%) ⇩ (Oct. 14, 2026, 6:04 p.m. EDT) |
Hot Take ↕ | Oct. 10, 2026, 5:33 a.m. EDT
The immediate outlook is neutral due to a lack of clear directional edge, despite recent headlines about patent filings and private placements which have fueled trading momentum. However, the long-term investment case is severely compromised by deteriorating fundamentals; the company is burning significant cash with negative free cash flow and operating cash flow, while returning losses on both assets and equity. The price action confirms this structural deterioration, having lost over 90% of its value over the trailing two-year period, indicating the market has already priced out the business quality. With no dividend to provide income and a balance sheet showing substantial cash burn against a shrinking market cap, the security represents a high-risk speculative play rather than a viable long-term holding. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.116574 |
| AutoETS | 0.130585 |
| AutoARIMA | 0.409627 |
| AutoTheta | 0.419154 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 0.78 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.482 |
| Excess Kurtosis | -0.87 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2008-04-22 |
| Market Cap | 6,131,961 |
| Forward P/E | -0.97 |
| Beta | 1.18 |
| Previous Name | Enveric Biosciences Inc. |
| Website | https://www.enveric.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.87314814 |
| Address1 | 245 First Street |
| Address2 | Riverview II 18 th Floor |
| All Time High | 182,250,000.0 |
| All Time Low | 1.17 |
| Ask | 1.88 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 79,780 |
| Average Daily Volume3 Month | 104,941 |
| Average Volume | 104,941 |
| Average Volume10Days | 79,780 |
| Beta | 1.18 |
| Bid | 1.09 |
| Bid Size | 2 |
| Book Value | 2.054 |
| City | Cambridge |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.37 |
| Current Ratio | 10.207 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 1.45 |
| Day Low | 1.33 |
| Display Name | Enveric Biosciences |
| Dividend Date | 1,574,640,000 |
| Dividend Yield | 0.0 |
| Earnings Timestamp End | 1,755,288,000 |
| Earnings Timestamp Start | 1,754,942,400 |
| Ebitda | -8,574,557 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.252 |
| Enterprise Value | -2,164,335 |
| Eps Forward | -1.41 |
| Eps Trailing Twelve Months | -13.01 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,208,908,800 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.471 |
| Fifty Day Average Change | -0.10099995 |
| Fifty Day Average Change Percent | -0.06866074 |
| Fifty Two Week Change Percent | -87.31481 |
| Fifty Two Week High | 13.25 |
| Fifty Two Week High Change | -11.88 |
| Fifty Two Week High Change Percent | -0.89660376 |
| Fifty Two Week Low | 1.17 |
| Fifty Two Week Low Change | 0.20000005 |
| Fifty Two Week Low Change Percent | 0.17094022 |
| Fifty Two Week Range | 1.17 - 13.25 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,430,746,200,000 |
| Float Shares | 4,337,892 |
| Forward Eps | -1.41 |
| Forward P E | -0.9716312 |
| Free Cashflow | -5,202,416 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 5 |
| Fullday Change | -0.059999943 |
| Fullday Change Percent | -4.2857103 |
| Fullday Price | 1.37 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.088929996 |
| Held Percent Institutions | 0.12019 |
| Implied Shares Outstanding | 4,475,884 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,761,609,600 |
| Last Split Factor | 1:12 |
| Long Business Summary | Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts. |
| Long Name | Enveric Biosciences, Inc. |
| Market | us_market |
| Market Cap | 6,131,961 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_650902272 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-10-14 |
| Net Income To Common | -12,088,531 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 6,892,861 |
| Open | 1.38 |
| Operating Cashflow | -8,561,197 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 617 444 8400 |
| Post Market Change | -0.029999971 |
| Post Market Change Percent | -2.189779 |
| Post Market Price | 1.34 |
| Post Market Time | 1,792,015,449 |
| Prev Name | Enveric Biosciences Inc. |
| Previous Close | 1.4 |
| Price Hint | 4 |
| Price To Book | 0.6669913 |
| Profit Margins | 0.0 |
| Quick Ratio | 9.63 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.03 |
| Regular Market Change Percent | -2.14286 |
| Regular Market Day High | 1.45 |
| Regular Market Day Low | 1.33 |
| Regular Market Day Range | 1.33 - 1.45 |
| Regular Market Open | 1.38 |
| Regular Market Previous Close | 1.4 |
| Regular Market Price | 1.37 |
| Regular Market Time | 1,792,008,001 |
| Regular Market Volume | 163,910 |
| Return On Assets | -0.87337995 |
| Return On Equity | -1.70036 |
| Sand P52 Week Change | 0.1570785 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 4,475,884 |
| Shares Percent Shares Out | 0.0034 |
| Shares Short | 15,435 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 12,873 |
| Short Name | Enveric Biosciences, Inc. |
| Short Percent Of Float | 0.0034999999 |
| Short Ratio | 0.25 |
| Source Interval | 15 |
| State | MA |
| Symbol | ENVB |
| Total Cash | 8,296,296 |
| Total Cash Per Share | 1.854 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -13.01 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.168565 |
| Two Hundred Day Average Change | -0.79856503 |
| Two Hundred Day Average Change Percent | -0.36824584 |
| Type Disp | Equity |
| Volume | 163,910 |
| Website | https://www.enveric.com |
| Zip | 2,142 |